Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Liabilities and Shareholders Equity: 2020-2025

Historic Liabilities and Shareholders Equity for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to $2.3 billion.

  • Core Scientific's Liabilities and Shareholders Equity rose 149.06% to $2.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 billion, marking a year-over-year increase of 133.63%. This contributed to the annual value of $1.6 billion for FY2024, which is 124.50% up from last year.
  • Latest data reveals that Core Scientific reported Liabilities and Shareholders Equity of $2.3 billion as of Q3 2025, which was up 16.07% from $2.0 billion recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Liabilities and Shareholders Equity ranged from a high of $2.7 billion in Q1 2022 and a low of $347.1 million during Q3 2021.
  • Over the past 3 years, Core Scientific's median Liabilities and Shareholders Equity value was $814.0 million (recorded in 2024), while the average stood at $1.2 billion.
  • As far as peak fluctuations go, Core Scientific's Liabilities and Shareholders Equity soared by 16,258,993.33% in 2021, and later slumped by 71.89% in 2023.
  • Over the past 5 years, Core Scientific's Liabilities and Shareholders Equity (Quarterly) stood at $2.4 billion in 2021, then tumbled by 66.88% to $807.7 million in 2022, then fell by 11.83% to $712.2 million in 2023, then spiked by 124.50% to $1.6 billion in 2024, then soared by 149.06% to $2.3 billion in 2025.
  • Its Liabilities and Shareholders Equity was $2.3 billion in Q3 2025, compared to $2.0 billion in Q2 2025 and $1.6 billion in Q1 2025.